Drug Trial Radar · NCT03583697
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Last checked: Nov 19, 2026Latest source record: Jun 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Actual
Start
Jun 13, 2018
Primary completion
Jan 26, 2022
Study completion Jan 26, 2022
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jul 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 59 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study 111-206 is a Phase 2 randomized, double-blind, placebo-controlled clinical trial of BMN 111 in infants and young children with a diagnosis of achondroplasia.
Conditions
- Achondroplasia
Interventions
BMN 111Drug
Subcutaneous injection of 15 μg/kg/day and/or 30 μg/kg/day of BMN 111 daily, subject to adjustment per protocol
PlaceboDrug
Subcutaneous injection of 15 μg/kg of placebo daily, Subject to adjustment per protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AEs) by Severity Grade and Study Drug Treatment-emergent Adverse Events (TEAEs)Time frame: Up to Week 56 (Safety Follow-Up +/-7d)
- Change From Baseline in Height Z-score at Week 52.Time frame: Baseline to Week 52
Locations
16 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital & Research Center Oakland
Oakland, California
Harbor - UCLA Medical Center
Torrance, California
Alfred I. duPont Hospital for Children
Wilmington, Delaware
Emory University
Decatur, Georgia
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Medical College of Wisconsin, Children's Hospital
Milwaukee, Wisconsin
The Children's Hospital at Westmead
Westmead, New South Wales, Australia
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Osaka University Hospital
Osaka, Japan
Saitama Children's Medical Center
Saitama, Japan
Tokushima University Hospital
Tokushima, Japan
Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital
London, United Kingdom
Sheffield Children's NHS Foundation Trust
Sheffield, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.